Diabetes Cure News!
Johnson & Johnson is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could fix and essentially cure the life-threatening hormonal disorder type 1 diabetes.
ViaCyte has already begun testing the device in a small number of diabetic patients. If it works as well in patients as it has in animals, it would amount to a cure, ending the need for frequent insulin injections and blood sugar testing. Watch the FOX5 news report above!
Read more about stem cells technology by ViaCyte.